Tag

Comparisons

Side-by-side compound comparisons.

Featured

Editor's picks.

Side-by-side comparison of retatrutide and tirzepatide across receptor profile, research context and analytical considerations.

All content

How retatrutide and semaglutide differ in receptor activity, compound class and laboratory research framing.

Comparisons

Triple vs dual incretin agonist — receptor profile and research framing.

Triple agonist vs single GLP-1 — class, mechanism and lab context.

Selective GLP-1 agonist vs dual GIP/GLP-1 agonist — receptor pharmacology and evidence comparison.

FAQ

Which is the newer research compound?

Retatrutide is the more recently characterised compound in the academic literature, while tirzepatide is the more established reference.

Are both compounds GLP-1 agonists?

Yes — both act on the GLP-1 receptor, but retatrutide also acts on GIP and glucagon receptors.